Anika (ANIK) Enterprise Value to EBITDA Ratio

Public company logo of Anika Therapeutics, Inc. (ANIK)

Anika Therapeutics (ANIK) specializes in developing orthopedic solutions and joint restoration treatments. The EV/EBITDA chart shows that this metric stands at 52.49. The business effectively scales the sale of proprietary implants and injections while maintaining low production costs. Anika Therapeutics (ANIK) leads the development of advanced biopolymers, investing heavily in scientific research. Material safety is complemented by strict waste disposal controls and sustainable resource consumption.

Anika Therapeutics, Inc. - ANIK Company Value to EBITDA (period 11/23/2025 - 11/16/2026)

Comprehensive metric breakdowns and analytics for Anika Therapeutics Inc. (ANIK)

- current price and projected stock value:
Analysis of all company metrics:Anika ANIK
Manufactured products of Anika Therapeutics, Inc.

Assessing the margin of safety for Anika Therapeutics (ANIK) requires an analysis of the enterprise value relative to its earnings before interest, taxes, depreciation, and amortization. This metric determines the return on investment speed while accounting for debt load and credit risks. The current EV/EBITDA multiple reflects the market's valuation of the company's cash flow generation efficiency. Stable demand for hyaluronic acid joint treatments should maintain this indicator within a sustainable range.

Competitor analysis

Boston Scientific Inc - Enterprise Value to EBITDA Ratio|Edwards Lifesciences (EW) - Company Value to EBITDA|ResMed Corporation - EV/EBITDA Multiple|Company Value to Operating Income Before Depreciation Ratio PODD|ZBH: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation COO|ALGN (Align Technology) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation GMED (Globus Medical)|Enterprise Value to EBITDA Ratio TMDX (TransMedics Group, Inc.)|ATEC (Alphatec Holdings) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Artivion Corp AORT|ENOV - Enterprise Value to EBITDA Ratio|Integra LifeSciences Corp - EV/EBITDA Multiple|Company Value to EBITDA Establishment Labs|BBNX: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation IRMD|EMBC (Embecta Health) - EV/EBITDA Multiple|Tandem Diabetes (TNDM) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple AXGN|Enterprise Value to EBITDA Ratio SI-BONE, Inc. SIBN|EV/EBITDA Multiple OFIX (orthofix.com)|Bioventus Corp - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|KIDS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TMCI: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SRTA (Strata Critical Medical Inc) - Enterprise Value to EBITDA Ratio|Carlsmed Inc - Business Value to Operating Income Before Depreciation|RXST (RxSight Ophthalmic) - EV/EBITDA Multiple|Company Value to EBITDA clearpointneuro.com CLPT|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Stereotaxis Inc (STXS)|Neuronetics, Inc. (STIM) - Enterprise Value to EBITDA Multiple|Sight Sciences Inc - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Orchestra BioMed, Inc. OBIO|InspireMD Inc - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio Jin Medical ZJYL|Vivani Medical (VANI) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio XTNT (Xtant Medical Inc)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization n1mtc.com|Enterprise Value to EBITDA Ratio Modular Medical (MODD)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Myomo, Inc (MYO)|COCH - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Vivos Therapeutics VVOS|NVNO: Enterprise Value to Operating Income Before Depreciation|SINT: Enterprise Value to EBITDA Ratio|Tenon Medical - Enterprise Value to Operating Income Before Depreciation Ratio|Lifeward (LFWD) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Autonomix Medical, Inc. (AMIX) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio IVF|Company Value to EBITDA Bone Biologics Inc BBLG|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Axonics Inc. (AXNX)|BIOL - Company Value to EBITDA|EV/EBITDA Multiple DYNT (Dynatronics Corp)|Enterprise Value to EBITDA Multiple Paragon 28, Inc.|INVO: Enterprise Value to EBITDA Ratio